The ATtune Knee Outcome Study
ATKOS
1 other identifier
observational
900
1 country
1
Brief Summary
To accomodate dissatisfied patients with a total knee arthroplasty (TKA) and improve outcomes, several knee systems have been developed. The cemented ATTUNE TKA shows superiority over other established knee systems at short-term, abating with longer follow-up. There have been no studies reporting on the results of the uncemented version of the ATTUNE. Therefore, the main objective of the current study was to report patient reported outcome measures (PROMs), survivorship and complications associated with the uncemented ATTUNE TKA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 20, 2020
CompletedFirst Posted
Study publicly available on registry
January 30, 2020
CompletedStudy Start
First participant enrolled
February 3, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 22, 2036
ExpectedApril 27, 2022
April 1, 2022
4 years
January 20, 2020
April 26, 2022
Conditions
Outcome Measures
Primary Outcomes (7)
Survivorship
Calculated by determining revision rate. Septic, aseptic and all-cause revision rates will be calculated seperately.
10 year
Complication rate
All substantial complications associated with total knee arthroplasty will be registered and reported
10 year
Forgotten Joint Score 12 (FJS-12)
10 year
Kujala Anterior Knee Pain Scale (AKPS)
10 year
Knee injury and Osteoarthritis Outcome Scale - Physical Function Short Form
KOOS-PS
10 year
Numeric Rating Scale (NRS)
NRS on pain and satisfaction
10 year
EuroQol 5 Dimensions, 3 Levels (EQ5D-3L)
10 year
Secondary Outcomes (10)
30 second chair stand test (30sCST)
1 year
40m Fast paced walk test (40m-FPWT)
1 year
Stair climb test (SCT)
1 year
Tegner activity rating scale
1 year
University of California, Los Angeles (UCLA) activity rating scale
1 year
- +5 more secondary outcomes
Interventions
All patients receive an uncemented ATTUNE rotating platform knee system.
Eligibility Criteria
All patients with end-stage knee disease (e.g. knee osteoarthritis) warranting and able to undergo knee replacement therapy.
You may qualify if:
- End-stage osteoarthritis of the knee warranting joint replacement therapy.
- Indicated for an ATTUNE total knee system as part of regular clinical practice.
- Capability and willingness to sign informed consent and comply with follow-up procedures.
- Capable enough in Dutch or English to be able to understand study procedures
You may not qualify if:
- Unable or unwilling to sign informed consent and comply with follow-up
- Indication for primary revision arthroplasty
- Absolute indication for cemented fixation (decreased bone stock/quality of spongiosa)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Spaarne Gasthuislead
Study Sites (1)
Spaarne Gasthuis
Hoofddorp, North Holland, 2134 TM, Netherlands
Related Publications (1)
Rassir R, Sierevelt IN, Schager M, Nolte PA; ATKOS group. Design and rationale of the ATtune Knee Outcome Study (ATKOS): multicenter prospective evaluation of a novel uncemented rotating platform knee system. BMC Musculoskelet Disord. 2021 Jul 15;22(1):622. doi: 10.1186/s12891-021-04493-1.
PMID: 34266444DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 20, 2020
First Posted
January 30, 2020
Study Start
February 3, 2020
Primary Completion
January 22, 2024
Study Completion (Estimated)
January 22, 2036
Last Updated
April 27, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share